Fresenius Kabi Swissbiosim Gmbh

This study follows 600 adults with moderate to severe rheumatoid arthritis who are already prescribed a biosimilar called Tyenne (similar to tocilizumab). Researchers want to see how many patients continue the treatment for 6 and 12 months. The study does not give any new medicin…